Medicus Pharma (MDCX) Operating Leases (2024 - 2026)
Medicus Pharma's (MDCX) quarterly Operating Leases came in at $205595.0 in Q4 2025, little changed YoY from $205945.0 in Q4 2024, and down 12.98% on a QoQ basis from $236258.0 in Q3 2025.
Medicus Pharma (MDCX) Operating Leases (2024 - 2026) Analysis & Trends
Medicus Pharma (MDCX) has 2 years of Operating Leases data on file, last reported at $205595.0 in Q4 2025.
- Quarterly Operating Leases changed 0.17% year-over-year to $205595.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $205595.0 (changed 0.17% YoY) and the FY2025 annual result came in at $205595.0, changed 0.17% from the prior year.
- Operating Leases slipped to $205595.0 in Q4 2025, from $236258.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $294693.0 in Q1 2025 to a low of $141753.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Medicus Pharma | 14.88 Mn | -298,205.43 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 137,330.00 |
| Dec 31, 2025 | 205,595.00 |
| Sep 30, 2025 | 236,258.00 |
| Jun 30, 2025 | 141,753.00 |
| Mar 31, 2025 | 294,693.00 |
| Dec 31, 2024 | 205,945.00 |